dexlansoprazole
Showing 1 - 23 of 23
Healthy, Bioequivalence Study Trial in Karachi (Dexlansoprazole)
Recruiting
- Healthy
- Bioequivalence Study
- Dexlansoprazole
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research
Sep 5, 2022
Gastro Esophageal Reflux Trial in Chicago (dexlansoprazole)
Enrolling by invitation
- Gastro Esophageal Reflux
- dexlansoprazole
-
Chicago, IllinoisNorthwestern Memorial Health Care
Dec 7, 2021
Erosive Esophagitis Trial in Worldwide (Dexlansoprazole)
Not yet recruiting
- Erosive Esophagitis
- Dexlansoprazole
-
Mobile, Alabama
- +44 more
Jun 13, 2022
Laryngopharyngeal Reflux Trial in Indianapolis (dexlansoprazole, Placebo)
Terminated
- Laryngopharyngeal Reflux
- dexlansoprazole
- Placebo
-
Indianapolis, IndianaClarian North Hospital -- IUMG Clinic
Sep 6, 2019
Pediatric Gastroesophageal Reflux Disease Trial in Worldwide (Dexlansoprazole)
Withdrawn
- Pediatric Gastroesophageal Reflux Disease
- Dexlansoprazole
-
Los Angeles, California
- +21 more
Apr 13, 2020
Healthy Volunteers Trial in Beijing (Dexlansoprazole)
Completed
- Healthy Volunteers
- Dexlansoprazole
-
Beijing, Beijing, ChinaPhase I Clinical Trial Department
Feb 8, 2019
Heartburn, Gastroesophageal Reflux Disease Trial in China (Dexlansoprazole, Placebo)
Completed
- Heartburn
- Gastroesophageal Reflux Disease
- Dexlansoprazole
- Placebo
-
Beijing, Beijing, China
- +24 more
Jul 3, 2019
Erosive Esophagitis Trial in China (Dexlansoprazole, Lansoprazole, Placebo)
Terminated
- Erosive Esophagitis
- Dexlansoprazole
- +2 more
-
Beijing, Beijing, China
- +24 more
Oct 11, 2018
Gastroesophageal Reflux Disease Trial in Hong Kong, Korea, Republic of, Taiwan (Dexlansoprazole)
Completed
- Gastroesophageal Reflux Disease
- Dexlansoprazole
-
Shatin, New Territories, Hong Kong
- +9 more
May 12, 2017
Barrett's Esophagus Trial in Jacksonville, Chapel Hill, Knoxville (Dexlansoprazole, Dexlansoprazole Placebo)
Terminated
- Barrett's Esophagus
- Dexlansoprazole
- Dexlansoprazole Placebo
-
Jacksonville, Florida
- +5 more
Mar 31, 2017
Laryngo-pharyngeal Reflux Trial in Seattle (Dexlansoprazole)
Withdrawn
- Laryngo-pharyngeal Reflux
- Dexlansoprazole
-
Seattle, WashingtonUniversity of Washington
Jun 30, 2017
Heartburn, Gastroesophageal Reflux Disease Trial in Chapel Hill (Dexlansoprazole)
Completed
- Heartburn
- Gastroesophageal Reflux Disease
- Dexlansoprazole
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Dec 16, 2016
Gastroesophageal Reflux Disease Trial (Dexlansoprazole, Lansoprazole)
Unknown status
- Gastroesophageal Reflux Disease
- Dexlansoprazole
- Lansoprazole
- (no location specified)
May 2, 2016
Inflammation, Barrett's Esophagus Trial in Rochester (dexlansoprazole, Omeprazole)
Completed
- Inflammation
- Barrett's Esophagus
- dexlansoprazole
- Omeprazole
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 19, 2016
Gastroesophageal Reflux Disease, Erosive Esophagitis Trial in Worldwide (Dexlansoprazole, Placebo)
Completed
- Gastroesophageal Reflux Disease
- Erosive Esophagitis
- Dexlansoprazole
- Placebo
-
Huntsville, Alabama
- +60 more
May 8, 2015
Gastroesophageal Reflux Disease, Erosive Esophagitis, Heartburn Trial in Woburn (Dexlansoprazole)
Completed
- Gastroesophageal Reflux Disease
- +2 more
- Dexlansoprazole
-
Woburn, Massachusetts(unnamed)
Feb 22, 2015
Homeostasis, Bone and Bones Trial in United States (Dexlansoprazole, Esomeprazole, Placebo)
Completed
- Homeostasis
- Bone and Bones
- Dexlansoprazole
- +2 more
-
San Diego, California
- +11 more
Mar 2, 2015
Gastroesophageal Reflux Disease Trial in Worldwide (Dexlansoprazole)
Completed
- Gastroesophageal Reflux Disease
- Dexlansoprazole
-
Huntsville, Alabama
- +64 more
Jul 14, 2014
Head Neck Cancer, Oropharyngeal Cancer, Gastroesophageal Reflux Disease Trial (Dexlansoprazole)
Withdrawn
- Head and Neck Cancer
- +2 more
- Dexlansoprazole
- (no location specified)
Sep 5, 2012
Gastroesophageal Reflux Trial in United States (Dexlansoprazole)
Completed
- Gastroesophageal Reflux
- Dexlansoprazole
-
Anaheim, California
- +3 more
Mar 8, 2012
Gastroesophageal Reflux Disease, Eosinophilic Esophagitis, Dysphagia Trial (dexlansoprazole)
Withdrawn
- Gastroesophageal Reflux Disease
- +2 more
- dexlansoprazole
- (no location specified)
Apr 18, 2012
Laryngopharyngeal Reflux, Hypertrophy of Lingual Tonsil Trial in Chicago (dexlansoprazole)
Unknown status
- Laryngopharyngeal Reflux
- Hypertrophy of Lingual Tonsil
- dexlansoprazole
-
Chicago, IllinoisAdvanced Center for Specialty Care
Apr 4, 2011
Gastroesophageal Reflux Trial in United States (Dexlansoprazole, Placebo)
Completed
- Gastroesophageal Reflux
- Dexlansoprazole
- Placebo
-
Tucson, Arizona
- +42 more
Apr 25, 2011